Stool antigen tests for helicobacter pylori infection: a review of clinical and cost-effectiveness and guidelines
CADTH
Record ID 32016000147
English
Authors' recommendations:
Certain commercially available stool antigen tests with high test performance (sensitivity and specificity) provide reliable results in the diagnosis of H. pylori infection and in follow-up testing after eradication therapy. The use of a stool antigen test-and-treat strategy in relieving symptoms of dyspepsia or reducing the burden of gastric cancer and peptic ulceration was cost-effective. Guidelines recommend a laboratory-based validated monoclonal stool test for test-and-treat strategies and for follow-up testing after eradication therapy.
Details
Project Status:
Completed
Year Published:
2015
URL for published report:
http://www.cadth.ca/sites/default/files/pdf/htis/jan-2015/RC0620_Stool%20antigen%20test_Final.pdf
English language abstract:
An English language summary is available
Publication Type:
Rapid Review
Country:
Canada
MeSH Terms
- Feces
- Helicobacter pylori
Contact
Organisation Name:
Canadian Agency for Drugs and Technologies in Health
Contact Address:
600-865 Carling Avenue, Ottawa, ON K1S 5S8 Canada. Tel: +1 613 226 2553; Fax: +1 613 226 5392;
Contact Name:
requests@cadth.ca
Contact Email:
requests@cadth.ca
Copyright:
Canadian Agency for Drugs and Technologies in Health (CADTH)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.